The next section of this article will elaborate on the key identified pathogen-based and immune-based mechanisms that support the plausibility of periodontitis in altering various aspects of immune checkpoint inhibitor-based immunotherapy by means of immune checkpoint molecules, mainly CTLA-4, PD-1, and PD-L1. The gene discussed is PDCD1; the disease is periodontitis.